Major depressive disorder (MDD) is a complex illness that is arising as a growing public health concern. Although several brain areas are related to this type of disorders, at the cellular level, the parvalbumin-positive cells of the hippocampus interplay a very relevant role. They control pyramidal cell bursts, neuronal networks, basic microcircuit functions, and other complex neuronal tasks involved in mood disorders. In resistant depressions, the efficacy of current antidepressant treatments drops dramatically, so the new rapid-acting antidepressants (RAADs) are being postulated as novel treatments. Ketamine at subanesthetic doses and its derivative metabolites have been proposed as RAADs due to their rapid and sustained action by blocking N-methyl-d-aspartate (NMDA) receptors, which in turn lead to the release of brain-derived neurotrophic factor (BDNF). This mechanism produces a rapid plasticity activation mediated by neurotransmitter homeostasis, synapse recovery, and increased dendritic spines and therefore, it is a promising therapeutic approach to improve cognitive symptoms in MDD.
BachmannS. Epidemiology of suicide and the psychiatric perspective.Int J Environ Res Public Health2018;15:1425
2.
LopizzoNBocchio ChiavettoLCattaneNPlazzottaGTaraziFIParianteCMRivaMACattaneoA. Gene-environment interaction in major depression: focus on experience-dependent biological systems.Front Psychiatry2015;6:68
3.
MalhiGSMannJJ. Depression.Lancet2018;392:2299–312
4.
NalleballeKReddy OntedduSSharmaRDanduVBrownAJastiMYadalaSVeerapaneniKSiddamreddySAvulaAKapoorNMudassarKKovvuruS. Spectrum of neuropsychiatric manifestations in COVID-19.Brain Behav Immun2020;88:71–4
5.
GargRK. Spectrum of neurological manifestations in Covid-19: a review.Neurol India2020;68:560–72
6.
BjörkholmCMonteggiaLM. BDNF – a key transducer of antidepressant effects.Neuropharmacology2016;102:72–9
7.
JeffersonTKellyCJMartinaM. Differential rearrangement of excitatory inputs to the medial prefrontal cortex in chronic pain models.Front Neural Circuits2021;15:791043
8.
BremnerJDNarayanMAndersonERStaibLHMillerHLCharneyDS. Hippocampal volume reduction in major depression.Am J Psychiatry2020;157:115–8
9.
ParkSC. Neurogenesis and antidepressant action.Cell Tissue Res2019; 377:95–106
10.
RadleyJJRocherABMillerMJanssenWGListonCHofPRMcEwenBSMorrisonJH. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex.Cereb Cortex2006;16:313–20
11.
TremblayRLeeSRudyB. GABAergic interneurons in the neocortex: from cellular properties to circuits.Neuron2016;91:260–92
12.
MallerJJWeltonTMiddioneMCallaghanFMRosenfeldJVGrieveSM. Revealing the hippocampal connectome through super-resolution 1150-direction diffusion MRI.Sci Rep2019;9:2418
13.
PriceJLDrevetsWC. Neurocircuitry of mood disorders.Neuropsychopharmacology2010;35:192–216
14.
HolmesSEScheinostDFinnemaSJNaganawaMDavisMTDellaGioiaNNabulsiNMatuskeyDAngaritaGAPietrzakRHDumanRSSanacoraGKrystalJHCarsonREEsterlisI. Lower synaptic density is associated with depression severity and network alterations.Nat Commun2019;10:1529
15.
YangYCuiYSangKDongYNiZMaSHuH. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression.Nature2018;554:317–22
16.
DengWAimoneJBGageFH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?Nat Rev Neurosci2010;11:339–50
17.
PapezJW. A proposed mechanism of emotion.J Neuropsychiatry Clin Neurosci1995;7:103–12
18.
KellerJGomezRWilliamsGLembkeALazzeroniLMurphyGMJrSchatzbergAF. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.Mol Psychiatry2017;22:527–36
19.
Urrutia-PiñonesJMorales-MoragaCSanguinetti-GonzálezNEscobarAPChiuCQ. Long-range GABAergic projections of cortical origin in brain function.Front Syst Neurosci2022;16:841869
20.
LismanJEGraceAA. The hippocampal-VTA loop: controlling the entry of information into long-term memory.Neuron2015;46: 703–13
21.
Warner-SchmidtJLDumanRS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment.Hippocampus2006;16: 239–49
22.
LebowMAChenA. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders.Mol Psychiatry2016;21:450–63
23.
DumanRSAghajanianGKSanacoraGKrystalJH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.Nat Med2016;22:238–49
24.
BelleauELTreadwayMTPizzagalliDA. The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology.Biol Psychiatry2019;85:443–53
25.
BoraEFornitoAPantelisCYücelM. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies.J Affect Disord2012;138:9–18
26.
ThompsonSMKallarackalAJKvartaMDVan DykeAMLeGatesTACaiX. An excitatory synapse hypothesis of depression.Trends Neurosci2015;38:279–94
27.
DrexelMRomanovRAWoodJWegerSHeilbronnRWulffPTasanROHarkanyTSperkG. Selective silencing of hippocampal parvalbumin interneurons induces development of recurrent spontaneous limbic seizures in mice.J Neurosci2017;37:8166–79
28.
FeeCBanasrMSibilleE. Somatostatin-positive gamma-aminobutyric acid interneuron deficits in depression: cortical microcircuit and therapeutic perspectives.Biol Psychiatry2017;82:549–59
29.
HemmingsHCEganTD. Pharmacology and physiology for anesthesia e-book: foundations and clinical application. Amsterdam: Elsevier Health Sciences, 2012
30.
ClarkBDGoldbergEMRudyB. Electrogenic tuning of the axon initial segment.Neuroscientist2009;15:651–68
31.
FishellGRudyB. Mechanisms of inhibition within the telencephalon: “where the wild things are.”Annu Rev Neurosci2011;34:535–67
32.
MassiLLaglerMHartwichKBorhegyiZSomogyiPKlausbergerT. Temporal dynamics of parvalbumin-expressing axo-axonic and basket cells in the rat medial prefrontal cortex in vivo.J Neurosci2012;32: 16496–502
33.
HullCIsaacsonJSScanzianiM. Postsynaptic mechanisms govern the differential excitation of cortical neurons by thalamic inputs.J Neurosci2009;29:9127–36
34.
HuHJonasP. A supercritical density of Na(+) channels ensures fast signaling in GABAergic interneuron axons.Nat Neurosci2014;17: 686–93
35.
BuetferingCAllenKMonyerH. Parvalbumin interneurons provide grid cell-driven recurrent inhibition in the medial entorhinal cortex.Nat Neurosci2014;17:710–8
36.
SpartaDRHovelsøNMasonAOKantakPAUngRLDecotHKStuberGD. Activation of prefrontal cortical parvalbumin interneurons facilitates extinction of reward-seeking behavior.J Neurosci2014;34: 3699–705
37.
HuHGanJJonasP. Interneurons. Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function.Science2014;345:1255263
38.
PiH-JJHangyaBKvitsianiDSandersJIHuangZJKepecsA. Cortical interneurons that specialize in disinhibitory control.Nature2013;503:521–4
39.
VadenRJGonzalezJCTsaiMCNiverAJFusilierARGriffithCMKramerRHWadicheJIOverstreet-WadicheL. Parvalbumin interneurons provide spillover to newborn and mature dentate granule cells.eLife2020;9:e54125
40.
MelzerSMichaelMCaputiAEliavaMFuchsECWhittingtonMAMonyerH. Long-range-projecting GABAergic neurons modulate inhibition in hippocampus and entorhinal cortex.Science2012;335:1506–10
41.
PittengerCDumanRS. Stress, depression, and neuroplasticity: a convergence of mechanisms.Neuropsychopharmacology2008;33:88–109
42.
IadarolaNDNiciuMJRichardsEMVande VoortJLBallardEDLundinNBNugentACMachado-VieiraRZarateCAJr.Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Ther Adv Chronic Dis2015; 6:97–114
43.
GaynesBNWardenDTrivediMHWisniewskiSRFavaMRushAJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.Psychiatr Serv2009;60:1439–45
44.
GouldTDZarateCAJrThompsonSM. Molecular pharmacology and neurobiology of rapid-acting antidepressants.Annu Rev Pharmacol Toxicol2019;59:213–36
45.
MullerJPentyalaSDilgerJPentyalaS. Ketamine enantiomers in the rapid and sustained antidepressant effects.Ther Adv Psychopharmacol2016;6:185–92
46.
BarreveldAMCorrellDJLiuXMaxBMcGowanJAShovelLWasanADNedeljkovicSS. Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study.Pain Med2013;14:925–34
47.
Reynaud-MauruptCBelloPYAkokaSToufikA. Characteristics and Behaviors of Ketamine Users in France in 2003.J Psychoactive Drugs2007;39:1–11
48.
BermanRMCappielloAAnandAOrenDAHeningerGRCharneyDSKrystalJH. Antidepressant effects of ketamine in depressed patients.Biol Psychiatry2000;47:351–4
49.
ZarateCAJrSinghJBCarlsonPJBrutscheNEAmeliRLuckenbaughDACharneyDSManjiHK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.Arch Gen Psychiatry2006;63:856–64
50.
GranryJCDubeLTurroquesHConreuxF. Ketamine: new uses for an old drug.Curr Opin Anaesthesiol2000;13:299–302
51.
SinghNSZarateCAJrMoaddelRBernierMWainerIW. What is hydroxynorketamine and what can it bring to neurotherapeutics?Expert Rev Neurother2014;14:1239–42
52.
DumanRSLiNLiuRJDuricVAghajanianG. Signaling pathways underlying the rapid antidepressant actions of ketamine.Neuropharmacology2012;62:35–41
53.
HomayounHMoghaddamB. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.J Neurosci2007;27:11496–500
54.
DwivediYRizaviHSConleyRRRobertsRCTammingaCAPandeyGN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.Arch Gen Psychiatry2003;60:804–15
55.
ShimizuEHashimotoKOkamuraNKoikeKKomatsuNKumakiriCNakazatoMWatanabeHShinodaNOkadaSIyoM. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.Biol Psychiatry2003;54:70–5
56.
LapidusKALevitchCFPerezAMBrallierJWParidesMKSoleimaniLFederAIosifescuDVCharneyDSMurroughJW. A randomized controlled trial of intranasal ketamine in major depressive disorder.Biol Psychiatry2014;76:970–6
57.
TahaEGildishIGal-Ben-AriSRosenblumK. The role of eEF2 pathway in learning and synaptic plasticity.Neurobiol Learn Mem2013;105:100–6
RyazanovAG. Elongation factor-2 kinase and its newly discovered relatives.FEBS Lett2002;514:26–9
60.
ZarateCABrutscheNLajeGLuckenbaughDAVenkataSLRamamoorthyAMoaddelRWainerIW. Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression.Biol Psychiatry2012;72:331–8
61.
LeungLYBaillieTA. Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine.J Med Chem1986;29:2396–9
62.
FukumotoKFogaçaMVLiuRJDumanCKatoTLiXYDumanRS. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.Proc Natl Acad Sci2019;116:297–302
63.
IbrahimLDiazgranadosNFranco-ChavesJBrutscheNHenterIDKronsteinPMoaddelRWainerILuckenbaughDAManjiHKZarateCAJr.Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.Neuropsychopharmacology2012;37:1526–33
64.
DalyEJSinghJBFedgchinMCooperKLimPSheltonRCThaseMEWinokurAVan NuetenLManjiHDrevetsWC. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression.JAMA Psychiatry2018;75:139–48
65.
FarmerCAGilbertJRMoaddelRGeorgeJAdeojoLLovettJNugentACKadriuBYuanPGouldTDParkLTZarateCAJr.Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.Neuropsychopharmacology2020;45:1398–404
66.
ZanosPMoaddelRMorrisPJGeorgiouPFischellJElmerGIAlkondonMYuanPPributHJSinghNSDossouKSFangYHuangXPMayoCLWainerIWAlbuquerqueEXThompsonSMThomasCJZarateCAJrGouldTD. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.Nature2016;533:481–6
67.
LiNLeeBLiuRJBanasrMDwyerJMIwataMLiXYAghajanianGDumanRS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.Science2010;329:959–64
68.
ChowdhuryGMZhangJThomasMBanasrMMaXPittmanBBristowLSchaefferEDumanRSRothmanDLBeharKLSanacoraG. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.Mol Psychiatry2017;22:120–6
69.
RenZPribiagHJeffersonSJShoreyMFuchsTStellwagenDLuscherB. Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment.Biol Psychiatry2016;80:457–68
70.
DumanCHDumanRS. Spine synapse remodeling in the pathophysiology and treatment of depression.Neurosci Lett2015;601:20–9
71.
PhoumthipphavongVBarthasFHassettSKwanAC. Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex.eNeuro2016;3
72.
LiNLiuRJDwyerJMBanasrMLeeBSonHLiXYAghajanianGDumanRS. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.Biol Psychiatry2011;69:754–61
73.
MarínO. Interneuron dysfunction in psychiatric disorders.Nat Rev Neurosci2012;13:107–20
74.
PozziLPollak DorocicIWangXCarlénMMeletisK. Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists.PLoS One2014;9:e83879
75.
PovyshevaNVGonzalez-BurgosGZaitsevAVKrönerSBarrionuevoGLewisDAKrimerLS. Properties of excitatory synaptic responses in fast-spiking interneurons and pyramidal cells from monkey and rat prefrontal cortex.Cereb Cortex2006;16:541–52
76.
ConstantinidisCGoldman-RakicPS. Correlated discharges among putative pyramidal neurons and interneurons in the primate prefrontal cortex.J Neurophysiol2002;88:3487–97
77.
ZhouZQZhangGFLiXMYangCYangJJ. Fast-spiking interneurons and gamma oscillations may be involved in the antidepressant effects of ketamine.Med Hypotheses2012;79:85–6
78.
MoghaddamBAdamsBVermaADalyD. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.J Neurosci1007;17:2921–7
79.
CornfordJHMercierMSLeiteMMagloireVHäusserMKullmannDM. Dendritic NMDA receptors in parvalbumin neurons enable strong and stable neuronal assemblies.eLife2019;8:e49872
80.
KinneyJWDavisCNTabareanIContiBBartfaiTBehrensMM. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons.J Neurosci2006;26:1604–15
81.
LismanJYasudaRRaghavachariS. Mechanisms of CaMKII action in long-term potentiation.Nat Rev Neurosci2012;13:169–82
82.
PaolettiPBelloneCZhouQ. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.Nat Rev Neurosci2013;14:383–400
83.
PicardNTakesianAEFagioliniMHenschTK. NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity.Mol Psychiatry2019;24:828–38
84.
GhosalSDumanCHLiuRJWuMTerwilligerRGirgentiMJWohlebEFogacaMVTeichmanEMHareBDumanRS. Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents.Neurobiol Dis2020;134:104669
85.
GerhardDMPothulaSLiuRJWuMLiXYGirgentiMJTaylorSRDumanCHDelpireEPicciottoMWohlebESDumanRS. GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions.J Clin Invest2020;130:1336–49
86.
StandaertDGLandwehrmeyerGBKernerJAPenneyJBJrYoungAB. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus.Brain Res Mol Brain Res1996;42:89–102
SapkotaKMaoZSynowickiPLieberDLiuMIkezuTGautamVMonaghanDT. GluN2D N-Methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia.J Pharmacol Exp Ther2016;356:702–11
89.
AntonoudiouPTanYLKontouGUptonALMannEO. Parvalbumin and somatostatin interneurons contribute to the generation of hippocampal gamma oscillations.J Neurosci2020;40:7668–87
90.
TukkerJJLasztócziBKatonaLRobertsJDPissadakiEKDaleziosYMártonLZhangLKlausbergerTSomogyiP. Distinct dendritic arborization and in vivo firing patterns of parvalbumin-expressing basket cells in the hippocampal area CA3.J Neurosci2013;33:6809–25
91.
Gonzalez-BurgosGChoRYLewisDA. Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.Biol Psychiatry2015;77:1031–40
92.
NgLHLHuangYHanLChangRCChanYSLaiCSW. Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination.Transl Psychiatry2018;8:272
